If you’ve been taking Ozempic or Wegovy (both of which contain the active ingredient semaglutide), you might wonder, How long ...

Among patients receiving semaglutide for obesity management, the risk for muscle loss may be higher in older adults and women ...

People who took semaglutide over a slower, more flexible schedule were significantly less likely to experience nausea and to ...

Weight loss injections can help people lose more weight than with other methods of weight loss, including lifestyle changes ...

Semaglutide, the active ingredient in Ozempic and Wegovy, is a glucagon-like peptide-1 (GLP-1) receptor agonist taken as a ...

Semaglutide, a popular anti-obesity drug, may come with a hidden cost: significant muscle loss, especially in women and older ...

Novo Nordisk is in the lead, but not alone. Obesity doctors say they are gearing up for demand, predicted to be high. Some ...

Semaglutide, also known by the brand names Ozempic and Wegovy, is quickly becoming a popular weight-loss medication. (Getty Images) Like nearly 50% of Americans, Talia (not her real name) had ...

Older age and female sex may be associated with greater muscle loss in adults with obesity prescribed semaglutide, and ...

Benefits were most prominent among women, patients older than 60 and those with a body mass index of 30 to 40.

Semaglutide, a weight-loss drug, showed promise for treating obesity in recent research. Demand quickly exceeded supply after the FDA in June approved once-weekly semaglutide injections.